Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Mechanism of action Tesamorelin is a selective agonist at the GHRH receptor (GHRHR), a class B G protein-coupled receptor expressed predominantly on somatotroph cells in the anterior pituitary
Dosing Schedules from Published Research Phase 2 Trial Dose Groups The Phase 2 clinical trial published in NEJM employed the following dose groups, all administered via subcutaneous injection once weekly: Scroll sideways to view the full table on mobile
503B facilities produce bulk quantities of compounded medications without patient-specific prescriptions
These medications, made of short chains of amino acids that naturally occur in the body, are currently unavailable to the public, but consumers have reportedly been accessing them through wellness clinics and online vendors under a research use only label
The study aimed to determine the effectiveness of ECFC transplantation in promoting vascular repair in the retinal area of mice, utilizing the oxygen-induced retinopathy (OIR) model for this purpose
US$ 20.10
US$ 27.79
US$ 23.73
US$ 22.91
US$ 26.86
US$ 20.54
